New anti-cancer drug: Exploring the Hong Kong price of selinesol

Selinexor is known as a new anti-cancer drug and has attracted widespread attention in the medical community for its unique nuclear transport inhibition mechanism. By precisely blocking the function of the nuclear transport protein XPO1, it has shown strong therapeutic potential for a variety of malignant tumors. The XPO1 protein plays a crucial role in intracellular gene expression and protein transport, and its abnormal activity is often closely linked to the development and progression of tumors. The ingenuity of selinesol is that it can precisely inhibit the function of XPO1, thereby interrupting the key protein transport chain within tumor cells and effectively curbing tumor proliferation and viability.

Multiple myeloma and lymphoma are selinesol's main targets. Multiple myeloma, a malignant disease originating from plasma cells, leads to severe impairment of bone marrow function and widespread deposition of tumor cells in bones. Lymphoma originates from the lymphatic system and has the characteristic of invading multiple tissues such as lymph nodes, spleen, and bone marrow. In the face of these difficult diseases, selinesol has demonstrated extraordinary therapeutic effects. It can cooperate with other anti-cancer drugs to significantly improve the survival and quality of life of patients.

In addition to the efficacy of drugs, the most concerning thing is the price of drugs. As a high-end innovative drug, Selinisol is naturally expensive. It is understood that the original Seleniso drug has been launched in China and is fortunately covered by medical insurance. Each box is priced at more than RMB 20,000. However, regarding the selling price of Seleniso in Hong Kong, patients or family members need to consult local hospitals or pharmacies with drug sales qualifications to obtain accurate information.